Serina Therapeutics (SER) announced that Randall Moreadith, CDO, will present new data at the ACS Spring 2025 Meeting and Expo in San Diego, ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, announced that Randall Moreadith, M ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 24, 2025. Let’s take ...

Strengthened key leadership with cell therapy and autoimmune expertise across organization Robust balance sheet with cash, ...

Antibodies against (a) cardiolipin (CL, IgG and IgM), β 2-glycoprotein-1 (β 2 GP-1, IgG) were determined in 661 patients and anti-prothrombin (aPT, IgG) were analysed in 593 patients by ELISA ...

As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...